Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma

NCT00046748 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
484
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals